Free Trial

MoonLake Immunotherapeutics (MLTX) Insider Trading & Ownership

MoonLake Immunotherapeutics logo
$52.17 +0.29 (+0.56%)
(As of 12/20/2024 05:16 PM ET)

MoonLake Immunotherapeutics (NASDAQ:MLTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.02%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$18.68 M
Get MLTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling MoonLake Immunotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MLTX Insider Buying and Selling by Quarter

MoonLake Immunotherapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/4/2024Simon SturgeDirectorSell171,000$53.72$9,186,120.00  
2/29/2024Da Silva Jorge SantosCEOSell4,740$55.89$264,918.60  
2/27/2024Da Silva Jorge SantosCEOSell62,810$55.00$3,454,550.00  
2/27/2024Kristian ReichInsiderSell29,431$55.00$1,618,705.00  
2/20/2024Da Silva Jorge SantosCEOSell20,000$57.44$1,148,800.00  
2/20/2024Kristian ReichInsiderSell10,000$57.43$574,300.00  
2/16/2024Kristian ReichInsiderSell10,000$60.15$601,500.00  
2/15/2024Da Silva Jorge SantosCEOSell20,000$60.18$1,203,600.00  
2/14/2024Kristian ReichInsiderSell10,000$62.43$624,300.00  
(Data available from 1/1/2013 forward)

MLTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at MoonLake Immunotherapeutics includes Bihua Chen, Da Silva Jorge Santos, Kristian Reich, Matthias Bodenstedt, and Simon Sturge. Learn more on insiders at MLTX.

12.02% of MoonLake Immunotherapeutics stock is owned by insiders. Learn more on MLTX's insider holdings.

The following insider purchased MLTX shares in the last 24 months: Bihua Chen ($80,319,331.74).

Insiders have purchased a total of 1,981,314 MLTX shares in the last 24 months for a total of $80,319,331.74 bought.

The following insiders have sold MLTX shares in the last 24 months: Da Silva Jorge Santos ($6,071,868.60), Kristian Reich ($3,418,805.00), Matthias Bodenstedt ($5,610,265.92), and Simon Sturge ($9,186,120.00).

Insiders have sold a total of 432,717 MoonLake Immunotherapeutics shares in the last 24 months for a total of $24,287,059.52 sold.

MoonLake Immunotherapeutics Key Executives

  • Dr. Jorge Santos da Silva (Age 46)
    Co-Founder, CEO & Director
    Compensation: $1.11M
  • Dr. Kristian Reich (Age 58)
    Co-Founder & Chief Scientific Officer
    Compensation: $1.2M
  • Mr. Matthias BodenstedtMr. Matthias Bodenstedt (Age 36)
    Chief Financial Officer
    Compensation: $588.25k
  • Mr. Oliver Daltrop
    Chief Technical Officer
  • Nicolas Mosimann
    General Counsel
  • Luciana Marques
    Director of HR, People & Culture
  • Ms. Nuala Brennan
    Chief Clinical Development Officer


This page (NASDAQ:MLTX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners